Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases
Open Access
- 1 January 2013
- journal article
- review article
- Published by Hindawi Limited in International Journal of Inflammation
- Vol. 2013, 1-15
- https://doi.org/10.1155/2013/403460
Abstract
The receptor for advanced glycation end products (RAGE) is a transmembrane receptor of the immunoglobulin superfamily, capable of binding a broad repertoire of ligands. RAGE-ligands interaction induces a series of signal transduction cascades and lead to the activation of transcription factor NF-B as well as increased expression of cytokines, chemokines, and adhesion molecules. These effects endow RAGE with the role in the signal transduction from pathogen substrates to cell activation during the onset and perpetuation of inflammation. RAGE signaling and downstream pathways have been implicated in a wide spectrum of inflammatory-related pathologic conditions such as arteriosclerosis, Alzheimer's disease, arthritis, acute respiratory failure, and sepsis. Despite the significant progress in other RAGE studies, the functional importance of the receptor in clinical situations and inflammatory diseases still remains to be fully realized. In this review, we will summarize current understandings and lines of evidence on the molecular mechanisms through which RAGE signaling contributes to the pathogenesis of the aforementioned inflammation-associated conditions.
Keywords
This publication has 139 references indexed in Scilit:
- The Receptor for Advanced Glycation End Products Is a Central Mediator of Asthma PathogenesisThe American Journal of Pathology, 2012
- Age-Related Changes in the Musculoskeletal System and the Development of OsteoarthritisClinics in Geriatric Medicine, 2010
- The dysregulation of intracellular calcium in Alzheimer diseaseCell Calcium, 2010
- Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's diseaseBrain Research, 2008
- α‐4/β‐1 and α‐L/β‐2 integrins mediate cytokine induced lung leukocyte‐epithelial adhesion and injuryBritish Journal of Pharmacology, 2007
- Structural and functional insights into RAGE activation by multimeric S100BThe EMBO Journal, 2007
- The Extracellular Region of the Receptor for Advanced Glycation End Products Is Composed of Two Independent Structural UnitsBiochemistry, 2007
- A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrinThe EMBO Journal, 2007
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996